Report Detail

Automobile & Transportation Global Cell and Gene Therapy Cold Chain Logistics Market 2023 by Company, Regions, Type and Application, Forecast to 2029

  • RnM4551835
  • |
  • 22 August, 2023
  • |
  • Global
  • |
  • 101 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Automobile & Transportation

According to our (Global Info Research) latest study, the global Cell and Gene Therapy Cold Chain Logistics market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Cell and Gene Therapy Cold Chain Logistics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Cell and Gene Therapy Cold Chain Logistics market size and forecasts, in consumption value ($ Million), 2018-2029
Global Cell and Gene Therapy Cold Chain Logistics market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Cell and Gene Therapy Cold Chain Logistics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Cell and Gene Therapy Cold Chain Logistics market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cell and Gene Therapy Cold Chain Logistics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cell and Gene Therapy Cold Chain Logistics market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AmerisourceBergen Corporation, Arvato Supply Chain Solutions SE, Be The Match BioTherapies, BioLife Solutions and Cardinal Health, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Cell and Gene Therapy Cold Chain Logistics market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Air Freight
Ground Transportation
Water Transport
Market segment by Application
Biopharmaceutical & Biotechnology Companies
Academic & Research Institutes
Others
Market segment by players, this report covers
AmerisourceBergen Corporation
Arvato Supply Chain Solutions SE
Be The Match BioTherapies
BioLife Solutions
Cardinal Health
Catalent
Cryoport
BioStor Sytems
Marken
Polar Express Transportation
Thermo Fisher Scientific
Yourway Biopharma Services Company
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Cell and Gene Therapy Cold Chain Logistics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cell and Gene Therapy Cold Chain Logistics, with revenue, gross margin and global market share of Cell and Gene Therapy Cold Chain Logistics from 2018 to 2023.
Chapter 3, the Cell and Gene Therapy Cold Chain Logistics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Cell and Gene Therapy Cold Chain Logistics market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Cell and Gene Therapy Cold Chain Logistics.
Chapter 13, to describe Cell and Gene Therapy Cold Chain Logistics research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Cell and Gene Therapy Cold Chain Logistics
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Cell and Gene Therapy Cold Chain Logistics by Type
    • 1.3.1 Overview: Global Cell and Gene Therapy Cold Chain Logistics Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global Cell and Gene Therapy Cold Chain Logistics Consumption Value Market Share by Type in 2022
    • 1.3.3 Air Freight
    • 1.3.4 Ground Transportation
    • 1.3.5 Water Transport
  • 1.4 Global Cell and Gene Therapy Cold Chain Logistics Market by Application
    • 1.4.1 Overview: Global Cell and Gene Therapy Cold Chain Logistics Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Biopharmaceutical & Biotechnology Companies
    • 1.4.3 Academic & Research Institutes
    • 1.4.4 Others
  • 1.5 Global Cell and Gene Therapy Cold Chain Logistics Market Size & Forecast
  • 1.6 Global Cell and Gene Therapy Cold Chain Logistics Market Size and Forecast by Region
    • 1.6.1 Global Cell and Gene Therapy Cold Chain Logistics Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global Cell and Gene Therapy Cold Chain Logistics Market Size by Region, (2018-2029)
    • 1.6.3 North America Cell and Gene Therapy Cold Chain Logistics Market Size and Prospect (2018-2029)
    • 1.6.4 Europe Cell and Gene Therapy Cold Chain Logistics Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific Cell and Gene Therapy Cold Chain Logistics Market Size and Prospect (2018-2029)
    • 1.6.6 South America Cell and Gene Therapy Cold Chain Logistics Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa Cell and Gene Therapy Cold Chain Logistics Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 AmerisourceBergen Corporation
    • 2.1.1 AmerisourceBergen Corporation Details
    • 2.1.2 AmerisourceBergen Corporation Major Business
    • 2.1.3 AmerisourceBergen Corporation Cell and Gene Therapy Cold Chain Logistics Product and Solutions
    • 2.1.4 AmerisourceBergen Corporation Cell and Gene Therapy Cold Chain Logistics Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 AmerisourceBergen Corporation Recent Developments and Future Plans
  • 2.2 Arvato Supply Chain Solutions SE
    • 2.2.1 Arvato Supply Chain Solutions SE Details
    • 2.2.2 Arvato Supply Chain Solutions SE Major Business
    • 2.2.3 Arvato Supply Chain Solutions SE Cell and Gene Therapy Cold Chain Logistics Product and Solutions
    • 2.2.4 Arvato Supply Chain Solutions SE Cell and Gene Therapy Cold Chain Logistics Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Arvato Supply Chain Solutions SE Recent Developments and Future Plans
  • 2.3 Be The Match BioTherapies
    • 2.3.1 Be The Match BioTherapies Details
    • 2.3.2 Be The Match BioTherapies Major Business
    • 2.3.3 Be The Match BioTherapies Cell and Gene Therapy Cold Chain Logistics Product and Solutions
    • 2.3.4 Be The Match BioTherapies Cell and Gene Therapy Cold Chain Logistics Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Be The Match BioTherapies Recent Developments and Future Plans
  • 2.4 BioLife Solutions
    • 2.4.1 BioLife Solutions Details
    • 2.4.2 BioLife Solutions Major Business
    • 2.4.3 BioLife Solutions Cell and Gene Therapy Cold Chain Logistics Product and Solutions
    • 2.4.4 BioLife Solutions Cell and Gene Therapy Cold Chain Logistics Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 BioLife Solutions Recent Developments and Future Plans
  • 2.5 Cardinal Health
    • 2.5.1 Cardinal Health Details
    • 2.5.2 Cardinal Health Major Business
    • 2.5.3 Cardinal Health Cell and Gene Therapy Cold Chain Logistics Product and Solutions
    • 2.5.4 Cardinal Health Cell and Gene Therapy Cold Chain Logistics Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Cardinal Health Recent Developments and Future Plans
  • 2.6 Catalent
    • 2.6.1 Catalent Details
    • 2.6.2 Catalent Major Business
    • 2.6.3 Catalent Cell and Gene Therapy Cold Chain Logistics Product and Solutions
    • 2.6.4 Catalent Cell and Gene Therapy Cold Chain Logistics Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Catalent Recent Developments and Future Plans
  • 2.7 Cryoport
    • 2.7.1 Cryoport Details
    • 2.7.2 Cryoport Major Business
    • 2.7.3 Cryoport Cell and Gene Therapy Cold Chain Logistics Product and Solutions
    • 2.7.4 Cryoport Cell and Gene Therapy Cold Chain Logistics Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Cryoport Recent Developments and Future Plans
  • 2.8 BioStor Sytems
    • 2.8.1 BioStor Sytems Details
    • 2.8.2 BioStor Sytems Major Business
    • 2.8.3 BioStor Sytems Cell and Gene Therapy Cold Chain Logistics Product and Solutions
    • 2.8.4 BioStor Sytems Cell and Gene Therapy Cold Chain Logistics Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 BioStor Sytems Recent Developments and Future Plans
  • 2.9 Marken
    • 2.9.1 Marken Details
    • 2.9.2 Marken Major Business
    • 2.9.3 Marken Cell and Gene Therapy Cold Chain Logistics Product and Solutions
    • 2.9.4 Marken Cell and Gene Therapy Cold Chain Logistics Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Marken Recent Developments and Future Plans
  • 2.10 Polar Express Transportation
    • 2.10.1 Polar Express Transportation Details
    • 2.10.2 Polar Express Transportation Major Business
    • 2.10.3 Polar Express Transportation Cell and Gene Therapy Cold Chain Logistics Product and Solutions
    • 2.10.4 Polar Express Transportation Cell and Gene Therapy Cold Chain Logistics Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Polar Express Transportation Recent Developments and Future Plans
  • 2.11 Thermo Fisher Scientific
    • 2.11.1 Thermo Fisher Scientific Details
    • 2.11.2 Thermo Fisher Scientific Major Business
    • 2.11.3 Thermo Fisher Scientific Cell and Gene Therapy Cold Chain Logistics Product and Solutions
    • 2.11.4 Thermo Fisher Scientific Cell and Gene Therapy Cold Chain Logistics Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Thermo Fisher Scientific Recent Developments and Future Plans
  • 2.12 Yourway Biopharma Services Company
    • 2.12.1 Yourway Biopharma Services Company Details
    • 2.12.2 Yourway Biopharma Services Company Major Business
    • 2.12.3 Yourway Biopharma Services Company Cell and Gene Therapy Cold Chain Logistics Product and Solutions
    • 2.12.4 Yourway Biopharma Services Company Cell and Gene Therapy Cold Chain Logistics Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Yourway Biopharma Services Company Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Cell and Gene Therapy Cold Chain Logistics Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of Cell and Gene Therapy Cold Chain Logistics by Company Revenue
    • 3.2.2 Top 3 Cell and Gene Therapy Cold Chain Logistics Players Market Share in 2022
    • 3.2.3 Top 6 Cell and Gene Therapy Cold Chain Logistics Players Market Share in 2022
  • 3.3 Cell and Gene Therapy Cold Chain Logistics Market: Overall Company Footprint Analysis
    • 3.3.1 Cell and Gene Therapy Cold Chain Logistics Market: Region Footprint
    • 3.3.2 Cell and Gene Therapy Cold Chain Logistics Market: Company Product Type Footprint
    • 3.3.3 Cell and Gene Therapy Cold Chain Logistics Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Cell and Gene Therapy Cold Chain Logistics Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global Cell and Gene Therapy Cold Chain Logistics Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global Cell and Gene Therapy Cold Chain Logistics Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global Cell and Gene Therapy Cold Chain Logistics Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America Cell and Gene Therapy Cold Chain Logistics Consumption Value by Type (2018-2029)
  • 6.2 North America Cell and Gene Therapy Cold Chain Logistics Consumption Value by Application (2018-2029)
  • 6.3 North America Cell and Gene Therapy Cold Chain Logistics Market Size by Country
    • 6.3.1 North America Cell and Gene Therapy Cold Chain Logistics Consumption Value by Country (2018-2029)
    • 6.3.2 United States Cell and Gene Therapy Cold Chain Logistics Market Size and Forecast (2018-2029)
    • 6.3.3 Canada Cell and Gene Therapy Cold Chain Logistics Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico Cell and Gene Therapy Cold Chain Logistics Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe Cell and Gene Therapy Cold Chain Logistics Consumption Value by Type (2018-2029)
  • 7.2 Europe Cell and Gene Therapy Cold Chain Logistics Consumption Value by Application (2018-2029)
  • 7.3 Europe Cell and Gene Therapy Cold Chain Logistics Market Size by Country
    • 7.3.1 Europe Cell and Gene Therapy Cold Chain Logistics Consumption Value by Country (2018-2029)
    • 7.3.2 Germany Cell and Gene Therapy Cold Chain Logistics Market Size and Forecast (2018-2029)
    • 7.3.3 France Cell and Gene Therapy Cold Chain Logistics Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom Cell and Gene Therapy Cold Chain Logistics Market Size and Forecast (2018-2029)
    • 7.3.5 Russia Cell and Gene Therapy Cold Chain Logistics Market Size and Forecast (2018-2029)
    • 7.3.6 Italy Cell and Gene Therapy Cold Chain Logistics Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific Cell and Gene Therapy Cold Chain Logistics Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific Cell and Gene Therapy Cold Chain Logistics Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific Cell and Gene Therapy Cold Chain Logistics Market Size by Region
    • 8.3.1 Asia-Pacific Cell and Gene Therapy Cold Chain Logistics Consumption Value by Region (2018-2029)
    • 8.3.2 China Cell and Gene Therapy Cold Chain Logistics Market Size and Forecast (2018-2029)
    • 8.3.3 Japan Cell and Gene Therapy Cold Chain Logistics Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea Cell and Gene Therapy Cold Chain Logistics Market Size and Forecast (2018-2029)
    • 8.3.5 India Cell and Gene Therapy Cold Chain Logistics Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia Cell and Gene Therapy Cold Chain Logistics Market Size and Forecast (2018-2029)
    • 8.3.7 Australia Cell and Gene Therapy Cold Chain Logistics Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America Cell and Gene Therapy Cold Chain Logistics Consumption Value by Type (2018-2029)
  • 9.2 South America Cell and Gene Therapy Cold Chain Logistics Consumption Value by Application (2018-2029)
  • 9.3 South America Cell and Gene Therapy Cold Chain Logistics Market Size by Country
    • 9.3.1 South America Cell and Gene Therapy Cold Chain Logistics Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil Cell and Gene Therapy Cold Chain Logistics Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina Cell and Gene Therapy Cold Chain Logistics Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa Cell and Gene Therapy Cold Chain Logistics Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa Cell and Gene Therapy Cold Chain Logistics Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa Cell and Gene Therapy Cold Chain Logistics Market Size by Country
    • 10.3.1 Middle East & Africa Cell and Gene Therapy Cold Chain Logistics Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey Cell and Gene Therapy Cold Chain Logistics Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia Cell and Gene Therapy Cold Chain Logistics Market Size and Forecast (2018-2029)
    • 10.3.4 UAE Cell and Gene Therapy Cold Chain Logistics Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 Cell and Gene Therapy Cold Chain Logistics Market Drivers
  • 11.2 Cell and Gene Therapy Cold Chain Logistics Market Restraints
  • 11.3 Cell and Gene Therapy Cold Chain Logistics Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry
  • 11.5 Influence of COVID-19 and Russia-Ukraine War
    • 11.5.1 Influence of COVID-19
    • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

  • 12.1 Cell and Gene Therapy Cold Chain Logistics Industry Chain
  • 12.2 Cell and Gene Therapy Cold Chain Logistics Upstream Analysis
  • 12.3 Cell and Gene Therapy Cold Chain Logistics Midstream Analysis
  • 12.4 Cell and Gene Therapy Cold Chain Logistics Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Cell and Gene Therapy Cold Chain Logistics. Industry analysis & Market Report on Cell and Gene Therapy Cold Chain Logistics is a syndicated market report, published as Global Cell and Gene Therapy Cold Chain Logistics Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Cell and Gene Therapy Cold Chain Logistics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,773.56
    4,160.34
    5,547.12
    3,246.84
    4,870.26
    6,493.68
    543,784.80
    815,677.20
    1,087,569.60
    290,475.60
    435,713.40
    580,951.20
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report